Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of ...
SHANGHAI, June 15 (Reuters) - China's Harbour BioMed said on Monday it would focus on another patent infringement case with ...
Harbour BioMed (HKEX: 02142.HK), a global biopharmaceutical company committed to the discovery and development of novel ...
Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with ...
The case, originally filed in 2021 by Harbour Antibodies, asserted that Amgen and Teneobio (an Amgen subsidiary) infringed ...
Orchestra BioMed has announced that the FDA has granted Breakthrough Device Designation for its atrioventricular interval modulation (AVIM) therapy, aimed at treating over 7.7 million U.S. patients ...
- BioMed Realty Continues to Support California’s Life Science Industry Growth with $2.6 Billion Capital Commitments in Last Four Years SAN DIEGO--(BUSINESS WIRE)--BioMed Realty (“BioMed”), a leading ...
SAN DIEGO--(BUSINESS WIRE)--BioMed Realty, a Blackstone portfolio company and leading provider of real estate solutions to the life science and technology industries, announced today that John Lee has ...
One of the biggest real estate investors in the world just made a deal that reinforces how the life sciences industry has been supercharged by the coronavirus pandemic. The internal transaction is the ...
View Orchestra BioMed Holdings, Inc. OBIO stock quote prices, financial information, real-time forecasts, and company news from CNN.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results